clofibrate has been researched along with Xanthoma in 43 studies
angiokapsul: contains clofibrate & insoitolnicotinate
Excerpt | Relevance | Reference |
---|---|---|
"The metabolism of cholesterol and its 5-dihydro derivative, cholestanol, was investigated by means of sterol balance and isotope kinetic techniques in 3 subjects with cerebrotendinous xanthomatosis (CTX) and 11 other individuals." | 7.65 | The metabolism of cholestanol, cholesterol, and bile acids in cerebrotendinous xanthomatosis. ( Grundy, SM; Salen, G, 1973) |
"Probucol was most effective in patients who experienced the greatest decreases in high density lipoprotein (HDL) levels, whereas the cholestyramine-compactin combination worked without decreasing HDL concentrations." | 5.27 | Effects of probucol on xanthomata regression in familial hypercholesterolemia. ( Funahashi, T; Kishino, B; Matsuzawa, Y; Yamamoto, A; Yamamura, T; Yokoyama, S, 1986) |
"The metabolism of cholesterol and its 5-dihydro derivative, cholestanol, was investigated by means of sterol balance and isotope kinetic techniques in 3 subjects with cerebrotendinous xanthomatosis (CTX) and 11 other individuals." | 3.65 | The metabolism of cholestanol, cholesterol, and bile acids in cerebrotendinous xanthomatosis. ( Grundy, SM; Salen, G, 1973) |
"Most patients with type III hyperlipoproteinemia have a structural defect in apolipoprotein E associated with increased synthesis and decreased catabolism of apolipoprotein E, delayed catabolism of chylomicron remnants, and development of plasma lipoprotein abnormalities characteristic of type III hyperlipoproteinemia." | 1.27 | NIH conference. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment. ( Brewer, HB; Gregg, RE; Schaefer, EJ; Schwartz, D; Zech, LA, 1983) |
"Eruptive and tubero-eruptive xanthomas arising at the site of previous minor skin injury are described in two patients with type IV and type III hyperlipidemia, respectively." | 1.27 | Eruptive and tubero-eruptive xanthomas of the skin arising on sites of prior injury. Two case reports. ( Davignon, J; Roederer, G; Xhignesse, M, 1988) |
"Probucol was most effective in patients who experienced the greatest decreases in high density lipoprotein (HDL) levels, whereas the cholestyramine-compactin combination worked without decreasing HDL concentrations." | 1.27 | Effects of probucol on xanthomata regression in familial hypercholesterolemia. ( Funahashi, T; Kishino, B; Matsuzawa, Y; Yamamoto, A; Yamamura, T; Yokoyama, S, 1986) |
"A patient with xanthoma disseminatum with typical xanthomatous lesions on the flexural surfaces and diabetes insipidus controllable by 1." | 1.26 | Xanthoma disseminatum. Report of a case, with histological and ultrastructural studies of skin lesions. ( Kumakiri, M; Miura, Y; Sudoh, M, 1981) |
"She developed eruptive xanthomata with a grossly raised serum triglyceride concentration and chylomicronaemia when pregnant and also when taking a combined oral contraceptive pill containing 50 microgram of oestrogen." | 1.26 | The effect of pregnancy and two different contraceptive pills on serum lipids and lipoproteins in a woman with a type III hyperlipoproteinaemia pattern. ( McLintock, D; Muller, DP; Pavlou, C; Whitelaw, AG, 1978) |
" This conclusion was strengthened by finding that long-term administration of the drug can cause marked reduction in body pools of cholesterol." | 1.25 | Mechanisms of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia. ( Ahrens, EH; Grundy, SM; Nestel, PJ; Salen, G; Schreibman, PH, 1972) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 43 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
SHARVILL, DE | 1 |
BORRIE, P | 2 |
OLIVER, MF | 1 |
MASON, B | 1 |
PERRY, CB | 1 |
MISHKEL, MA | 2 |
Asagami, C | 1 |
Nishioka, K | 1 |
Kawamura, K | 1 |
Yamamoto, T | 1 |
Shiraishi, M | 1 |
Brewer, HB | 1 |
Zech, LA | 1 |
Gregg, RE | 1 |
Schwartz, D | 1 |
Schaefer, EJ | 1 |
Kumakiri, M | 1 |
Sudoh, M | 1 |
Miura, Y | 1 |
McIntyre, N | 1 |
Harry, DS | 1 |
Pearson, AJ | 1 |
Hellström, K | 1 |
Einarsson, K | 1 |
Falko, JM | 1 |
Witztum, JL | 1 |
Schonfeld, G | 1 |
Weidman, SW | 1 |
Kolar, JB | 1 |
Lehtonen, A | 1 |
Viikari, J | 1 |
Muller, DP | 1 |
Pavlou, C | 1 |
Whitelaw, AG | 1 |
McLintock, D | 1 |
Válek, J | 1 |
Grafnetter, D | 1 |
Englis, M | 1 |
Matl, I | 1 |
Cockshott, WP | 1 |
Nazir, DJ | 1 |
Rosenthal, D | 1 |
Spaulding, WP | 1 |
Wynn-Williams, A | 1 |
Bickley, L | 1 |
Roederer, G | 1 |
Xhignesse, M | 1 |
Davignon, J | 2 |
Yamamoto, A | 1 |
Matsuzawa, Y | 1 |
Yokoyama, S | 1 |
Funahashi, T | 1 |
Yamamura, T | 1 |
Kishino, B | 1 |
Parker, F | 2 |
Segall, MM | 1 |
Fosbrooke, AS | 1 |
Lloyd, JK | 1 |
Wolff, OH | 1 |
Rufli, T | 1 |
Stähelin, H | 1 |
Salen, G | 2 |
Grundy, SM | 2 |
Kwiterovich, PO | 1 |
Margolis, S | 1 |
Polano, MK | 1 |
Frenk, E | 1 |
Walker, AE | 1 |
Edwards, IR | 1 |
Cloarec, M | 2 |
Jepson, EM | 1 |
Wolfram, G | 2 |
Bobnis, W | 1 |
Szmatloch, E | 1 |
Wesolowska, T | 1 |
Wójcicki, J | 1 |
Zieliński, T | 1 |
Weber, K | 1 |
Braun-Falco, O | 1 |
Slack, J | 1 |
Short, JM | 1 |
Amidi, M | 1 |
Mazovetskiĭ, AG | 1 |
Alekseev, IuP | 1 |
Kliachko, VR | 1 |
Ahrens, EH | 1 |
Schreibman, PH | 1 |
Nestel, PJ | 1 |
Kudchodkar, BJ | 1 |
Sodhi, HS | 1 |
Horlick, L | 1 |
Ruhrmann, H | 1 |
Aubry, F | 1 |
Noël, C | 1 |
Lapierre, Y | 1 |
Lafortune, M | 1 |
Moschella, SL | 1 |
Storey, GO | 1 |
Fanta, D | 1 |
Formanek, I | 1 |
Niebauer, G | 1 |
Duncan, GG | 1 |
Elliott, FA | 1 |
Duncan, TG | 1 |
Schatanoff, J | 1 |
5 reviews available for clofibrate and Xanthoma
Article | Year |
---|---|
The hypercholesterolaemia of obstructive jaundice.
Topics: Animals; Bile Ducts; Cholestasis; Cholesterol; Cholestyramine Resin; Clofibrate; Electrophoresis, Po | 1975 |
Bile acid metabolism in hyperlipoproteinaemia.
Topics: Bile Acids and Salts; Cholelithiasis; Cholesterol; Cholestyramine Resin; Cholic Acids; Chylomicrons; | 1977 |
Type IV hyperlipoproteinaemia.
Topics: Child; Cholesterol; Chylomicrons; Clofibrate; Diagnosis, Differential; Diet Therapy; Dietary Carbohy | 1973 |
Therapeutics XIX. Lipid lowering agents.
Topics: Animals; Arteriosclerosis; Blood Protein Disorders; Cholestyramine Resin; Clofibrate; Coronary Disea | 1972 |
Xanthomatosis associated with hyperlipoproteinemia.
Topics: Anticholesteremic Agents; Blood Protein Disorders; Cholestyramine Resin; Chylomicrons; Clofibrate; D | 1970 |
2 trials available for clofibrate and Xanthoma
Article | Year |
---|---|
Long-term effect of the combination of calcium clofibrate and calcium carbonate on serum total cholesterol, triglyceride and high density lipoprotein--cholesterol concentrations in hyperlipoproteinaemia. A comparative study with clofibrate.
Topics: Adult; Calcium Carbonate; Cholesterol; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Li | 1979 |
Treatment of familial hypercholesterolaemia in children.
Topics: Adolescent; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Clofibrate; Diet Therapy; Di | 1970 |
36 other studies available for clofibrate and Xanthoma
Article | Year |
---|---|
HYPERLIPAEMIC XANTHOMATOSIS TREATED WITH CLOFIBRATE. 'DRY DISCOID ECZEMA'.
Topics: Butyrates; Cholesterol; Clofibrate; Eczema; Humans; Hyperlipidemias; Triparanol; Xanthomatosis | 1964 |
THE TREATMENT OF XANTHOMATOSIS WITH ATROMID.
Topics: Androsterone; Blood Chemical Analysis; Butyrates; Clofibrate; Hypercholesterolemia; Hyperlipidemias; | 1964 |
ATROMID-S AND ATROMID.
Topics: Androsterone; Arteriosclerosis; Butyrates; Cerebrovascular Disorders; Clofibrate; Coronary Disease; | 1964 |
EFFECT OF CLOFIBRATE AND ANDROSTERONE ON HYPERCHOLESTEROLAEMIC XANTHOMATOSIS.
Topics: Androsterone; Butyrates; Clofibrate; Hypercholesterolemia; Pharmacology; Xanthomatosis | 1965 |
THE TREATMENT OF XANTHOMATOSIS WITH "ATROMID".
Topics: Androsterone; Blood Chemical Analysis; Butyrates; Clofibrate; Drug Therapy; Hypercholesterolemia; Hy | 1964 |
[Electron microscopic studies of eruptive xanthomas with type V hyperlipoproteinemia, in regressing stage of xanthoma by clofibrate therapy].
Topics: Adult; Clofibrate; Humans; Hyperlipoproteinemia Type V; Male; Microscopy, Electron; Skin Diseases; X | 1984 |
NIH conference. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment.
Topics: Adolescent; Adult; Aged; Apolipoproteins; Clofibrate; Coronary Vessels; Diet; Female; Humans; Hyperl | 1983 |
Xanthoma disseminatum. Report of a case, with histological and ultrastructural studies of skin lesions.
Topics: Adult; Autophagy; Clofibrate; Cytoplasm; Diabetes Insipidus; Female; Histiocytes; Humans; Microscopy | 1981 |
Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy.
Topics: Adult; Apolipoproteins; Cholesterol; Clofibrate; Female; Humans; Hyperlipidemias; Lipoproteins, HDL; | 1979 |
The effect of pregnancy and two different contraceptive pills on serum lipids and lipoproteins in a woman with a type III hyperlipoproteinaemia pattern.
Topics: Adult; Cholesterol; Chylomicrons; Clofibrate; Contraceptives, Oral; Contraceptives, Oral, Combined; | 1978 |
[An unusual case of hyperlipoproteinemia type III manifestation].
Topics: Aged; Clofibrate; Humans; Hyperlipidemias; Immunoglobulin A; Male; Multiple Myeloma; Xanthomatosis | 1978 |
Xanthoma disseminatum. Clinical, metabolic, pathologic, and radiologic aspects.
Topics: Anus Diseases; Bone and Bones; Cholesterol; Clofibrate; Humans; Liver; Male; Middle Aged; Mouth Dise | 1977 |
Yellow papules on a middle-aged woman. Eruptive xanthomatosis (EX).
Topics: Biopsy; Clofibrate; Dietary Fats; Female; Humans; Hyperlipidemias; Middle Aged; Skin Diseases; Trigl | 1989 |
Eruptive and tubero-eruptive xanthomas of the skin arising on sites of prior injury. Two case reports.
Topics: Adult; Clofibrate; Female; Gemfibrozil; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Male; M | 1988 |
Effects of probucol on xanthomata regression in familial hypercholesterolemia.
Topics: Achilles Tendon; Adolescent; Adult; Aged; Anticholesteremic Agents; Child; Child, Preschool; Cholest | 1986 |
Xanthomas and hyperlipidemias.
Topics: Apoproteins; Arteriosclerosis; Cholestasis; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyr | 1985 |
[Xanthomatosis as a symptom of hyperlipidemic metabolic disorders. Relationship of the morphological picture to the lipid of three patients].
Topics: Adult; Arterial Occlusive Diseases; Blood Protein Electrophoresis; Cholestyramine Resin; Chylomicron | 1972 |
The metabolism of cholestanol, cholesterol, and bile acids in cerebrotendinous xanthomatosis.
Topics: Adult; Aged; Bile Acids and Salts; Brain Diseases; Carbon Radioisotopes; Cholestanol; Cholesterol; C | 1973 |
Xanthomatosis and hyperlipoproteinemia; a review.
Topics: Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Chylomicrons; Clofibrate; Diet, Reducing; D | 1974 |
[Classification and treatment of hyperlipidemia: normolipemic treatments in 1972].
Topics: Aluminum; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Triglycerides; Xanthomatosis | 1972 |
Do fats matter.
Topics: Arteries; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Coronary Di | 1972 |
Reversibility of lipid deposition.
Topics: Arteriosclerosis; Cholesterol; Clofibrate; Cornea; Coronary Disease; Coronary Vessels; Evaluation St | 1973 |
[Case of primary hyperlipemia treated with cynarin].
Topics: Cinnamates; Clofibrate; Cyclohexanecarboxylic Acids; Humans; Hyperlipidemias; Male; Middle Aged; Xan | 1973 |
[Hyperlipoproteinemia type 3. Report on 5 cases].
Topics: Adult; Blood Protein Electrophoresis; Body Weight; Cholesterol; Clofibrate; Diagnosis, Differential; | 1973 |
A clinical syndrome characteristic of primary Type IV-V hyperlipoproteinaemia.
Topics: Abdomen; Adult; Cholesterol; Chylomicrons; Clofibrate; Diabetes Complications; Diet, Reducing; Elect | 1974 |
Type IV hyperlipoproteinemia in a consanguinous family.
Topics: Adult; Aged; Allopurinol; Clofibrate; Consanguinity; Dietary Carbohydrates; Female; Glucose Toleranc | 1972 |
[Treatment of diabetic xanthomatosis with Atromid].
Topics: Clofibrate; Diabetes Complications; Diabetes Mellitus; Humans; Male; Middle Aged; Xanthomatosis | 1972 |
Mechanisms of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia.
Topics: Adult; Aged; Bile; Bile Acids and Salts; Carbon Isotopes; Child; Cholesterol; Cholestyramine Resin; | 1972 |
Lack of degradation of dietary and endogenous sterols in gastrointestinal tract of man.
Topics: Adult; Angina Pectoris; Cholesterol; Clofibrate; Coronary Disease; Diet; Digestive System; Feces; Fe | 1972 |
[Serum cholesterol and total serum lipids of psoriasis patients in comparison with healthy persons and other diseases].
Topics: Adolescent; Adult; Aged; Child; Cholesterol; Clofibrate; Eczema; Female; Humans; Hyperlipidemias; Li | 1972 |
[Treatment of hyperlipoproteinemia in relation to recent classifications].
Topics: Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Nicotinic Acids; Thyroid Ho | 1971 |
Heterogeneity on familial hyperlipoproteinemia type II on the basis of fasting plasma triglyceride-cholesterol ratio and plasma cholesterol response to ethyl p-chlorophenoxyisobutyrate.
Topics: Adult; Blood Glucose; Blood Protein Disorders; Cholesterol; Clofibrate; Coronary Disease; Fasting; F | 1971 |
Xanthomatosis, associated with multiple myeloma.
Topics: Clofibrate; Humans; Lipid Metabolism; Liver Diseases; Male; Melphalan; Middle Aged; Multiple Myeloma | 1970 |
Xanthomatosis, hyperlipoproteinaemia (type II, Fredrickson), gout, cardiac infarction.
Topics: Adult; Cholesterol; Clofibrate; Gout; Humans; Hyperlipidemias; Indomethacin; Lipoproteins; Male; Myo | 1971 |
[Behavior of lipoproteins in xanthomatoses].
Topics: Clofibrate; Diabetes Mellitus; Diet Therapy; Humans; Hypoglycemic Agents; Lipoproteins; Obesity; Ski | 1971 |
Some clinical potentials of chlorophenoxyisobutyrate (Clofibrate) therapy. (Hyperlipidemia--angina pectoris--blood sludging--diabetic neuropathy).
Topics: Adult; Aged; Angina Pectoris; Anticoagulants; Blood Coagulation Disorders; Clofibrate; Diabetic Neur | 1968 |